NO20010718D0 - Ny saltform av pantoprazol - Google Patents

Ny saltform av pantoprazol

Info

Publication number
NO20010718D0
NO20010718D0 NO20010718A NO20010718A NO20010718D0 NO 20010718 D0 NO20010718 D0 NO 20010718D0 NO 20010718 A NO20010718 A NO 20010718A NO 20010718 A NO20010718 A NO 20010718A NO 20010718 D0 NO20010718 D0 NO 20010718D0
Authority
NO
Norway
Prior art keywords
pantoprazole
salt form
new salt
new
dihydrate
Prior art date
Application number
NO20010718A
Other languages
English (en)
Other versions
NO20010718L (no
NO319782B1 (no
Inventor
Bernhard Kohl
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20010718(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NO20010718L publication Critical patent/NO20010718L/no
Publication of NO20010718D0 publication Critical patent/NO20010718D0/no
Publication of NO319782B1 publication Critical patent/NO319782B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Drying Of Gases (AREA)
  • Detergent Compositions (AREA)
  • Manufacture And Refinement Of Metals (AREA)
NO20010718A 1998-08-18 2001-02-12 Pantoprazol-magnesiumdihydrat, medikamenter inneholdende denne og anvendelsen derav NO319782B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843413A DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
PCT/EP1999/005928 WO2000010995A1 (en) 1998-08-18 1999-08-12 Novel salt form of pantoprazole

Publications (3)

Publication Number Publication Date
NO20010718L NO20010718L (no) 2001-02-12
NO20010718D0 true NO20010718D0 (no) 2001-02-12
NO319782B1 NO319782B1 (no) 2005-09-12

Family

ID=7881823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010718A NO319782B1 (no) 1998-08-18 2001-02-12 Pantoprazol-magnesiumdihydrat, medikamenter inneholdende denne og anvendelsen derav

Country Status (33)

Country Link
US (2) US6410569B1 (no)
EP (1) EP1105386B1 (no)
JP (1) JP2002523411A (no)
KR (1) KR100657835B1 (no)
CN (1) CN1146558C (no)
AT (1) ATE219074T1 (no)
AU (1) AU761715B2 (no)
BG (1) BG65255B1 (no)
BR (1) BR9914288A (no)
CA (1) CA2341031C (no)
CZ (1) CZ293734B6 (no)
DE (3) DE19843413C1 (no)
DK (1) DK1105386T3 (no)
EA (1) EA004431B1 (no)
EE (1) EE04278B1 (no)
ES (1) ES2178896T3 (no)
HK (1) HK1037616A1 (no)
HR (1) HRP20010117B1 (no)
HU (1) HU226618B1 (no)
IL (3) IL141328A0 (no)
ME (1) ME00562A (no)
MX (1) MXPA01001758A (no)
NO (1) NO319782B1 (no)
NZ (1) NZ509761A (no)
PL (1) PL198801B1 (no)
PT (1) PT1105386E (no)
RS (1) RS50071B (no)
SI (1) SI1105386T1 (no)
SK (1) SK285105B6 (no)
TR (1) TR200100287T2 (no)
UA (1) UA58605C2 (no)
WO (1) WO2000010995A1 (no)
ZA (1) ZA200100934B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
CA2510849A1 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
WO2004098599A2 (en) * 2003-05-06 2004-11-18 Altana Pharma Ag Proton pump inhibitors for the treatment of lower abdominal disorders
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
EP1631284A2 (en) * 2003-05-19 2006-03-08 Pliva-Istrazivanje I Razvoj D.D.O. Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes
EP1615913A2 (en) * 2003-06-10 2006-01-18 Teva Pharmaceutical Industries Limited Process for preparing 2-(pyridinyl)methyl sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
ATE386522T1 (de) * 2003-07-23 2008-03-15 Nycomed Gmbh Alkalisalze von protonenpumpen-hemmern
US20080234326A1 (en) * 2004-01-28 2008-09-25 Altana Pharma Ag Novel Salts of Pantoprazole and (S) - Pantoprazole
WO2005074932A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag The use of (s) - pantoprazole magnesium for the treatment of airway disorders
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
EP1716136A1 (en) * 2004-02-11 2006-11-02 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridine benzimidazole sulfoxides of high purity
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
EP1746980B1 (en) * 2004-05-07 2011-11-02 Nycomed GmbH Pharmaceutical dosage form comprising pellets as well as its manufacturing process
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
WO2007146341A2 (en) 2006-06-12 2007-12-21 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of pantoprazole magnesium salt
US20080177076A1 (en) * 2006-11-06 2008-07-24 Lilach Hedvanti Processes for preparing substantially pure pantoprazole magnesium
WO2017114898A1 (en) * 2015-12-30 2017-07-06 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of pantoprazole sodium sesquihydrate
EP3187494A1 (en) * 2015-12-30 2017-07-05 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of pantoprazole sodium sesquihydrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE4018642C2 (de) 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
SE9302396D0 (sv) 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol

Also Published As

Publication number Publication date
NZ509761A (en) 2003-08-29
DE69901840T2 (de) 2003-05-22
ES2178896T3 (es) 2003-01-01
US20020188008A1 (en) 2002-12-12
DE122005000049I1 (de) 2006-12-28
DE19843413C1 (de) 2000-03-30
SK285105B6 (sk) 2006-06-01
NO20010718L (no) 2001-02-12
AU761715B2 (en) 2003-06-05
KR20010072487A (ko) 2001-07-31
HUP0103257A2 (hu) 2002-02-28
SK2362001A3 (en) 2001-09-11
DE122005000049I2 (de) 2007-03-29
ME00562B (me) 2011-12-20
DK1105386T3 (da) 2002-09-30
AU5515699A (en) 2000-03-14
CN1146558C (zh) 2004-04-21
CZ2001621A3 (cs) 2001-08-15
RS50071B (sr) 2009-01-22
IL141157A (en) 2007-06-17
CZ293734B6 (cs) 2004-07-14
EE04278B1 (et) 2004-04-15
YU11301A (sh) 2003-12-31
US6410569B1 (en) 2002-06-25
NO319782B1 (no) 2005-09-12
EA200100208A1 (ru) 2001-08-27
SI1105386T1 (en) 2002-12-31
PL345993A1 (en) 2002-01-14
US6686379B2 (en) 2004-02-03
HUP0103257A3 (en) 2003-01-28
CA2341031C (en) 2006-04-04
EP1105386B1 (en) 2002-06-12
EA004431B1 (ru) 2004-04-29
PL198801B1 (pl) 2008-07-31
TR200100287T2 (tr) 2001-07-23
EE200100054A (et) 2002-06-17
HRP20010117B1 (en) 2010-07-31
EP1105386A1 (en) 2001-06-13
HK1037616A1 (en) 2002-02-15
BR9914288A (pt) 2001-06-19
BG105173A (en) 2001-11-30
ME00562A (en) 2011-12-20
CN1318065A (zh) 2001-10-17
HU226618B1 (en) 2009-04-28
ZA200100934B (en) 2002-03-04
HRP20010117A2 (en) 2002-02-28
ATE219074T1 (de) 2002-06-15
MXPA01001758A (es) 2002-04-17
BG65255B1 (bg) 2007-10-31
CA2341031A1 (en) 2000-03-02
DE69901840D1 (de) 2002-07-18
JP2002523411A (ja) 2002-07-30
IL141328A0 (en) 2002-03-10
UA58605C2 (uk) 2003-08-15
PT1105386E (pt) 2002-11-29
IL141157A0 (en) 2002-02-10
KR100657835B1 (ko) 2006-12-15
WO2000010995A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
NO20010718L (no) Ny saltform av pantoprazol
TR200000782T2 (tr) Resorsinol türevleri.
IS6655A (is) Sýklópentanóindól, efnablöndur sem innihalda slíkefnasambönd og meðhöndlunaraðferðir
ID27092A (id) Pembuatan ftalat anhidrida
ID29021A (id) Komposisi galantamina pelepasan terkontrol
DE60225040D1 (de) Montelukast-granulatformulierung
NO20010899L (no) Forbedring av ugunstige apomorfin-effekter
ATE274348T1 (de) Überbrückte indenopyrrolocarbazole
NO20013943D0 (no) Fremgangsmate for fremstilling av Citalopram
NO994790L (no) Estimering av permabilitet
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
EE200300294A (et) Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
SE9801494D0 (sv) Novel use
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
NO20025703D0 (no) Fremgangsmåte for fremstilling av vannfritt natriumperklorat
DE50207869D1 (de) Metallorganisches antitumormittel
TR199900757A3 (tr) Fenoksifenilsülfonil halidlerin hazirlanmasi için islem.
FI982810A0 (fi) Menetelmä 3-asetoksi-2-metyylibentsoyylikloridin valmistamiseksi
ID19319A (id) Metoda yang diperbaiki untuk pembuatan mikrogel-mikrogel polialuminosilikat berkonsentrasi rendah
DE69814092D1 (de) Wassermischbare Arzneizusammensetzung von Nimesulide
IT1305242B1 (it) Preparatore di mazzi di pelli.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

MM1K Lapsed by not paying the annual fees